DANSK BIOTEK organizes four major plenary meetings for our members throughout the year to increase our members' knowledge regarding specific biotech topics and to facilitate networking. The events usually take place in February, May, September and November.

We also organize approximately six "saloon" meetings annually. They are small, intimate, "meet the expert" meetings with typically 6-20 participants advocating more in-depth discussion and knowledge-sharing on specific themes.

23 Oct 2012

Genzyme i alliance med Alnylam vedr. RNAi lægemidler i Asien

Alnylam Pharmaceuticals og Genzyme, der ejes af Sanofi har indgået partnerskab om at udvikle og markedsføre RNAi lægemidler rettet mod transthyretin (TTR) til behandling af transthyretin-mediated amyloidosis (ATTR) i Japan og andre Asien-Pacific lande. ATTR er en sjælden, arvelig sygdom som ødelægger nervesystsm og hjerte.

If you can't find it here or have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or +45 5150 0560

Copyright 2012 Danskbiotek. All rights reserved.